Insiders · TRAX

TRAX insider transactions

First Tracks Biotherapeutics Inc. (TRAX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TRAX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at First Tracks Biotherapeutics Inc., latest first. Follow anyone to get their next filing.

• Ajim TamboliChief Financial Officer, since April 2026
• Daniel FagaPresident, CEO, Director, since April 2026
• Benjamin StoneChief Business Officer, since April 2026
• Paul F. LizzulChief Medical Officer, since April 2026
• John A OrwinDirector
• J. Anthony WareDirector
• John P. SchmidDirector
• Magda MarquetDirector
• Rita JainDirector
• Dennis M FentonDirector
• EcoR1 Capital, LLC10% owner, since April 2026
• Anaptysbio, Inc10% owner, since April 2026

Recent Form 3, 4, and 5 filings for TRAX

• 5d
  Chief Financial Officer Tamboli Ajim was granted 42,500 shares (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 5d
  President, CEO Faga Daniel was granted 136,000 shares (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 5d
  Chief Business Officer Stone Benjamin was granted 42,500 shares (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 5d
  Chief Medical Officer Lizzul Paul F. was granted 42,500 shares (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 52d
  Director Orwin John A converted options into 1,300 shares, increasing direct ownership by 8% to 17,995 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 82d
  SEC Form 4 filed by Chief Business Officer Stone Benjamin

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 82d
  SEC Form 4 filed by President, CEO Faga Daniel

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 82d
  SEC Form 4 filed by Chief Medical Officer Lizzul Paul F.

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 93d
  Amendment: SEC Form 3 filed by new insider Lizzul Paul F.

  3/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 93d
  Amendment: SEC Form 3 filed by new insider Stone Benjamin

  3/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 93d
  Amendment: SEC Form 3 filed by new insider Faga Daniel

  3/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 95d
  SEC Form 4 filed by Chief Business Officer Stone Benjamin

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 95d
  SEC Form 4 filed by Chief Medical Officer Lizzul Paul F.

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 95d
  SEC Form 4 filed by President, CEO Faga Daniel

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 144d
  Director Schmid John P. converted options into 6,030 shares, increasing direct ownership by 19% to 37,652 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 144d
  Director Marquet Magda converted options into 6,030 shares, increasing direct ownership by 61% to 15,960 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 144d
  Director Jain Rita converted options into 7,330 shares, increasing direct ownership by 62% to 19,194 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 144d
  Director Orwin John A converted options into 6,030 shares, increasing direct ownership by 57% to 16,695 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 144d
  Director Ware J. Anthony converted options into 6,030 shares, increasing direct ownership by 63% to 15,660 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 144d
  Director Fenton Dennis M converted options into 6,030 shares, increasing direct ownership by 121% to 10,995 units (SEC Form 4)

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 149d
  Amendment: SEC Form 4 filed by Director Fenton Dennis M

  4/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 149d
  Amendment: SEC Form 4 filed by Director Jain Rita

  4/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 149d
  Amendment: SEC Form 4 filed by Director Marquet Magda

  4/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 149d
  Amendment: SEC Form 4 filed by Director Orwin John A

  4/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 149d
  Amendment: SEC Form 4 filed by Director Schmid John P.

  4/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 149d
  Amendment: SEC Form 4 filed by Director Ware J. Anthony

  4/A - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Director Jain Rita

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Director Ware J. Anthony

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Director Schmid John P.

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Director Marquet Magda

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Director Fenton Dennis M

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Chief Business Officer Stone Benjamin

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Director Orwin John A

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Chief Financial Officer Tamboli Ajim

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by President, CEO Faga Daniel

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 178d
  SEC Form 4 filed by Chief Medical Officer Lizzul Paul F.

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 199d
  SEC Form 3 filed by new insider Tamboli Ajim

  3 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 199d
  SEC Form 4 filed by Chief Financial Officer Tamboli Ajim

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Ecor1 Capital, Llc

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 3 filed by new insider Ecor1 Capital, Llc

  3 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 3 filed by new insider Stone Benjamin

  3 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Ware J. Anthony

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Lizzul Paul F.

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Jain Rita

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Orwin John A

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Schmid John P.

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Fenton Dennis M

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Marquet Magda

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Anaptysbio, Inc

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
• 200d
  SEC Form 4 filed by Faga Daniel

  4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)